Apolipoprotein E region molecular signatures of Alzheimer's disease

被引:25
|
作者
Kulminski, Alexander M. [1 ]
Huang, Jian [1 ]
Wang, Jiayi [1 ]
He, Liang [1 ]
Loika, Yury [1 ]
Culminskaya, Irina [1 ]
机构
[1] Duke Univ, Biodemog Aging Res Unit, Social Sci Res Inst, Durham, NC 27708 USA
关键词
age-related phenotypes; aging; Alzheimer's disease; APOE polymorphism; health span; lifespan; neurodegenerative disorders; LINKAGE-DISEQUILIBRIUM; MISSENSE MUTATIONS; GENE; ASSOCIATION; APOE; EVOLUTION; POLYMORPHISMS; ASTROCYTES; EXPRESSION; LONGEVITY;
D O I
10.1111/acel.12779
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the APOE region is the strongest genetic risk factor for Alzheimer's diseases (ADs), its pathogenic role remains poorly understood. Elucidating genetic predisposition to ADs, a subset of age-related diseases characteristic for postreproductive period, is hampered by the undefined role of evolution in establishing molecular mechanisms of such diseases. This uncertainty is inevitable source of natural-selection-free genetic heterogeneity in predisposition to ADs. We performed first large-scale analysis of linkage disequilibrium (LD) structures characterized by 30 polymorphisms from five genes in the APOE 19q13.3 region (BCAM, ECTIN2, TOMM40, APOE, and APOC1) in 2,673 AD-affected and 16,246 unaffected individuals from five cohorts. Consistent with the undefined role of evolution in age-related diseases, we found that these structures, being highly heterogeneous, are significantly different in subjects with and without ADs. The pattern of the difference represents molecular signature of AD comprised of single nucleotide polymorphisms (SNPs) from all five genes in the APOE region. Significant differences in LD in subjects with and without ADs indicate SNPs from different genes likely involved in AD pathogenesis. Significant and highly heterogeneous molecular signatures of ADs provide unprecedented insight into complex polygenetic predisposition to ADs in the APOE region. These findings are more consistent with a complex haplotype than with a single genetic variant origin of ADs in this region.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Apolipoprotein E and Alzheimer's disease
    Benjamin R.Troutwine
    Laylan Hamid
    Colton R.Lysaker
    Taylor A.Strope
    Heather M.Wilkins
    [J]. Acta Pharmaceutica Sinica B, 2022, 12 (02) : 496 - 510
  • [2] Apolipoprotein E and Alzheimer's disease
    Strittmatter, WJ
    Roses, AD
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1996, 19 : 53 - 77
  • [3] Apolipoprotein E and Alzheimer's disease
    Stephens, D
    [J]. JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1996, 116 (01): : 41 - 43
  • [4] Apolipoprotein E and Alzheimer's disease
    Troutwine, Benjamin R.
    Hamid, Laylan
    Lysaker, Colton R.
    Strope, Taylor A.
    Wilkins, Heather M.
    [J]. ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 496 - 510
  • [5] Apolipoprotein E and Alzheimer's disease
    Strittmatter, WJ
    [J]. ALZEHEIMER'S DISEASE: A COMPENDIUM OF CURRENT THEORIES, 2000, 924 : 91 - 92
  • [6] Role of apolipoprotein E in the pathogenesis of Alzheimer's disease and molecular mechanisms
    Song, Zhenhai
    Xu, Shuo
    Song, Bin
    Zhang, Qinghua
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04): : 4615 - 4621
  • [7] Apolipoprotein E and Alzheimer's disease:: molecular mechanisms and therapeutic opportunities
    Cedazo-Minguez, Angel
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (06) : 1227 - 1238
  • [8] Apolipoprotein E and Alzheimer's disease; a genetic, molecular and neuroimaging review
    Swartz, RE
    Black, SE
    St George-Hyslop, P
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 (02) : 77 - 88
  • [9] Apolipoprotein E and survival in Alzheimer's disease
    Rocca, WA
    Waring, SC
    Tangalos, EG
    Kokmen, E
    Petersen, RC
    [J]. NEUROLOGY, 1996, 46 (02) : 55003 - 55003
  • [10] The Role of Apolipoprotein E in Alzheimer's Disease
    Kim, Jungsu
    Basak, Jacob M.
    Holtzman, David M.
    [J]. NEURON, 2009, 63 (03) : 287 - 303